article · The European Journal of Health Economics
OBJECTIVES: This study aimed to examine the psychometric performance of the proxy-reported EQ-5D-Y-3L (Y-3L) for children living with spinal muscular atrophy (SMA) aged between 5 and 12 years, with a particular focus on examining whether its properties differ across three age groups. METHODS: Patients were recruited through a nation-wide patient advocacy association in China. Parents of eligible patients were invited to complete a web-based survey. Proxy-reported cross-sectional data from children aged 5-12 years were included in the analysis and categorized into three age groups: 5-6, 7-8, and 9-12 years. Convergent validity, known-groups validity, and the explanatory power of the Y-3L were assessed across the three age groups as well as in the overall sample. RESULTS: The Y-3L showed strong ceiling effects for "pain/discomfort" and "feeling worried, sad, or unhappy," and floor effects in the three physical dimensions. Ceiling effects generally decreased with age for "pain/discomfort" and "feeling worried, sad, or unhappy." Level sum scores and index values correlated moderately to strongly with other measures. Four dimensions correlated well with comparator scales, but "doing usual activities" showed weaker links. Known-groups validity was highest for Y-3L, with clear age differences. Y-3L dimensions explained less EQ VAS variance with age, while emotional problems were more influential in 5-6-year-olds. CONCLUSION: The Y-3L is a valid instrument for assessing health-related quality of life in SMA children aged between 5 and 12 years, with better psychometric properties observed in older children aged over 7 years.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1007/s10198-026-01980-x
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.